Oramed Pharma

ORMP

4.0501.94% ( -0.080 )

Trading: Oct 26, 14:05:14 (EDT)

Current ValuationThe current P/E ratio is 0.99, below the reasonable range, cheaper than 93.08% of the time in the past 1 years, and the industry ranks 3/256, the industry Median -1.11.

0.987xP/E

Stock price$4.13Earnings per share$4.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS	9.56x	5.05%	$172.71B
SGIOYUSShionogi	9.71x	--	$16.36B
INVAUSInnoviva	4.18x	32.30%	$1.49B
OMERUSOmeros	9.61x	1,913.34%	$1.20B
APMDUSApnimed	4.62x	114.94%	$756.24M
CRMDUSCormedix	3.29x	75.74%	$611.86M
ORMPUSOramed Pharma	0.99x	198.00%	$171.80M
OGIUSOrganigram	2.01x	509.06%	$125.04M
SDEVUSStablecoin Development	0.10x	--	$50.62M
BTMDUSbiote Corp.	6.56x	127.70%	$38.44M
OWPCUSOne World Products, Inc.	0.00x	--	$17.80K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.